Mahatinib

DB18236InvestigationalSmall molecule

Mahatinib: Overview.

Mechanism: Pharmacologically active on Activated CDC42 kinase 1
Curator reviewed
Also known as: (R)-9b

Resolves to

Compound

Targets

What you can answer from here — as of September 12, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Mahatinib, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.